1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > France In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

France In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "France In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the France In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the France In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

France In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 In Vitro Diagnostics Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 13
3 In Vitro Diagnostics Market, France 26
3.1 In Vitro Diagnostics Market, France, Revenue ($m), 2007-2021 26
3.2 In Vitro Diagnostics Market, France, Revenue Mix ($m), 2014 28
3.3 In Vitro Diagnostics Market, France, Category Contribution by Revenue ($m), 2014 29
3.4 In Vitro Diagnostics Market, France, Category Comparison by Revenue ($m), 2007-2021 30
3.5 In Vitro Diagnostics Market, France, Revenue ($m), 2007-2014 32
3.6 In Vitro Diagnostics Market, France, Revenue ($m), 2014-2021 34
3.7 In Vitro Diagnostics Market, France, Company Share by Revenue ($m), 2014 36
4 Clinical Chemistry Market, France 38
4.1 Clinical Chemistry Market, France, Revenue Mix ($m), 2014 38
4.2 Clinical Chemistry Market, France, Segment Contribution (%), 2014 39
4.3 Clinical Chemistry Market, France, Revenue ($m), 2007-2014 41
4.4 Clinical Chemistry Market, France, Revenue ($m), 2014-2021 43
4.5 Clinical Chemistry Market, France, Distribution Share by Revenue ($m), 2013-2014 57
4.6 Clinical Chemistry Market, France, Company Share by Revenue ($m), 2014 58
5 Genetic Testing Market, France 60
5.1 Genetic Testing Market, France, Revenue Mix ($m), 2014 60
5.2 Genetic Testing Market, France, Segment Contribution (%), 2014 61
5.3 Genetic Testing Market, France, Revenue ($m), 2007-2014 62
5.4 Genetic Testing Market, France, Revenue ($m), 2014-2021 64
5.5 Genetic Testing Market, France, Distribution Share by Revenue ($m), 2013-2014 66
5.6 Genetic Testing Market, France, Company Share by Revenue ($m), 2014 67
6 Haematology Market, France 69
6.1 Haematology Market, France, Revenue Mix ($m), 2014 69
6.2 Haematology Market, France, Segment Contribution (%), 2014 70
6.3 Haematology Market, France, Revenue ($m), 2007-2014 71
6.4 Haematology Market, France, Revenue ($m), 2014-2021 73
6.5 Haematology Market, France, Distribution Share by Revenue ($m), 2013-2014 95
6.6 Haematology Market, France, Company Share by Revenue ($m), 2014 96
7 Histology And Cytology Market, France 98
7.1 Histology And Cytology Market, France, Revenue Mix ($m), 2014 98
7.2 Histology And Cytology Market, France, Segment Contribution (%), 2014 99
7.3 Histology And Cytology Market, France, Revenue ($m), 2007-2014 100
7.4 Histology And Cytology Market, France, Revenue ($m), 2014-2021 102
7.5 Histology And Cytology Market, France, Distribution Share by Revenue ($m), 2013-2014 104
7.6 Histology And Cytology Market, France, Company Share by Revenue ($m), 2014 105
8 Immuno Chemistry Market, France 107
8.1 Immuno Chemistry Market, France, Revenue Mix ($m), 2014 107
8.2 Immuno Chemistry Market, France, Segment Contribution (%), 2014 108
8.3 Immuno Chemistry Market, France, Revenue ($m), 2007-2014 110
8.4 Immuno Chemistry Market, France, Revenue ($m), 2014-2021 112
8.5 Immuno Chemistry Market, France, Distribution Share by Revenue ($m), 2013-2014 142
8.6 Immuno Chemistry Market, France, Company Share by Revenue ($m), 2014 143
9 Infectious Diagnostics Market, France 145
9.1 Infectious Diagnostics Market, France, Revenue Mix ($m), 2014 145
9.2 Infectious Diagnostics Market, France, Segment Contribution (%), 2014 146
9.3 Infectious Diagnostics Market, France, Revenue ($m), 2007-2014 148
9.4 Infectious Diagnostics Market, France, Revenue ($m), 2014-2021 150
9.5 Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), 2013-2014 156
9.6 Infectious Diagnostics Market, France, Company Share by Revenue ($m), 2014 157
10 Microbiology Culture Market, France 159
10.1 Microbiology Culture Market, France, Revenue Mix ($m), 2014 159
10.2 Microbiology Culture Market, France, Segment Contribution (%), 2014 160
10.3 Microbiology Culture Market, France, Revenue ($m), 2007-2014 161
10.4 Microbiology Culture Market, France, Revenue ($m), 2014-2021 163
10.5 Microbiology Culture Market, France, Distribution Share by Revenue ($m), 2013-2014 169
10.6 Microbiology Culture Market, France, Company Share by Revenue ($m), 2014 170
11 Overview of Key Companies in France, In Vitro Diagnostics Market 172
11.1 Siemens Healthcare 172
11.2 F. Hoffmann-La Roche Ltd. 172
11.3 Abbott Laboratories 172
11.4 bioMerieux S.A. 173
11.5 Danaher Corporation 173
11.6 Becton, Dickinson and Company 173
11.7 Sysmex Corporation 174
11.8 Qiagen N.V. 174
11.9 Bio-Rad Laboratories, Inc. 174
11.10 Ortho-Clinical Diagnostics Inc. 175
11.11 Thermo Fisher Scientific Inc. 175
11.12 Horiba, Ltd. 175
12 In Vitro Diagnostics Market Pipeline Products 176
13 Financial Deals Landscape 182
13.1 Acquisition 182
13.2 Debt Offerings 184
13.3 Equity Offerings 185
13.4 Merger 191
13.5 Partnerships 192
13.6 Venture Financing 228
14 Recent Developments 233
14.1 Corporate Communications 233
14.2 Financial Announcements 241
14.3 Government and Public Interest 294
14.4 Legal And Regulatory 295
14.5 Other Significant Developments 295
14.6 Product News 308
14.7 Strategy And Business Planning 311
15 Appendix 316
15.1 Research Methodology 317
15.2 GlobalData Consulting 318
15.3 Contact Us 318
15.4 Disclaimer 319

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, France, Revenue ($m), USD Constant, 2007-2021 31
Table 2: In Vitro Diagnostics Market, France, Category Contribution by Revenue ($m), 2014 33
Table 3: In Vitro Diagnostics Market, France, Category Comparison by Revenue ($m), USD Constant, 2007-2021 35
Table 4: In Vitro Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 5: In Vitro Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 6: In Vitro Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2014 41
Table 7: Clinical Chemistry Market, France, Segment Contribution (%), 2014 44
Table 8: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 9: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 10: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 11: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 12: Urine Analysis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 13: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 14: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 15: Urine Analysis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 16: Clinical Chemistry Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 61
Table 17: Clinical Chemistry Market, France, Company Share by Revenue ($m), USD Constant, 2014 63
Table 18: Genetic Testing Market, France, Segment Contribution (%), 2014 65
Table 19: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 67
Table 20: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Table 21: Genetic Testing Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 70
Table 22: Genetic Testing Market, France, Company Share by Revenue ($m), USD Constant, 2014 72
Table 23: Haematology Market, France, Segment Contribution (%), 2014 74
Table 24: Haematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 76
Table 25: Haematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Table 26: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 80
Table 27: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 82
Table 28: Haematology Reagents Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 84
Table 29: Haemostasis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 30: Immunohaematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 88
Table 31: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Table 32: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Table 33: Haematology Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 34: Haemostasis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 35: Immunohaematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Table 36: Haematology Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 99
Table 37: Haematology Market, France, Company Share by Revenue ($m), USD Constant, 2014 101
Table 38: Histology And Cytology Market, France, Segment Contribution (%), 2014 103
Table 39: Histology And Cytology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 105
Table 40: Histology And Cytology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Table 41: Histology And Cytology Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 108
Table 42: Histology And Cytology Market, France, Company Share by Revenue ($m), USD Constant, 2014 110
Table 43: Immuno Chemistry Market, France, Segment Contribution (%), 2014 113
Table 44: Immuno Chemistry Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 115
Table 45: Immuno Chemistry Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 117
Table 46: Anemia Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 119
Table 47: Disease Specific Immunochemistry Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 48: Endocrinology Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 123
Table 49: IgE Allergy Blood Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 50: Immunochemistry Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 51: Immunochemistry Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 52: Vitamins Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 53: Anemia Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Table 54: Disease Specific Immunochemistry Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 55: Endocrinology Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Table 56: IgE Allergy Blood Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 57: Immunochemistry Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 58: Immunochemistry Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 59: Vitamins Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Table 60: Immuno Chemistry Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 146
Table 61: Immuno Chemistry Market, France, Company Share by Revenue ($m), USD Constant, 2014 148
Table 62: Infectious Diagnostics Market, France, Segment Contribution (%), 2014 151
Table 63: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 153
Table 64: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Table 65: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 157
Table 66: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 159
Table 67: Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 160
Table 68: Infectious Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2014 162
Table 69: Microbiology Culture Market, France, Segment Contribution (%), 2014 164
Table 70: Microbiology Culture Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 166
Table 71: Microbiology Culture Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 168
Table 72: Microbiology Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 170
Table 73: Microbiology Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 172
Table 74: Microbiology Culture Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 173
Table 75: Microbiology Culture Market, France, Company Share by Revenue ($m), USD Constant, 2014 175
Table 76: I n Vitro Diagnostics Market Pipeline Products 180
Table 77: Eurofins Scientific to Acquire Biomnis for USD250 Million 186
Table 78: Novacyt Raises USD0.27 Million in First Tranche Private Placement of Bonds 188
Table 79: Novacyt Raises USD2.16 Million in Private Placement of Shares 189
Table 80: Visiomed Group Completes Private Placement of Shares for USD6.8 Million 190
Table 81: Genfit Raises USD26 Million in Private Placement of Shares 191
Table 82: Novacyt to Raise USD3 Million in Private Placement of Shares 192
Table 83: Biosynex Raises USD1.2 Million in Rights Offering of Shares 193
Table 84: Erytech Pharma Raises USD38 Million in Private Placement of Shares 194
Table 85: Biosynex to Merge with Prodiag 195
Table 86: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 196
Table 87: Seegene Enters into Co-Development Agreement with BD Life Sciences 197
Table 88: MdxHealth Enters into Licensing Agreement with Erasmus MC 198
Table 89: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 199
Table 90: Sigma-Aldrich Enters into Distribution Agreement with LGC 200
Table 91: OvaGene Oncology Enters into Agreement with Etta Healthcare 201
Table 92: InTouch Health Enters into Agreement with iSchemaView 202
Table 93: TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 203
Table 94: Vigilant Biosciences Enters into Co-Marketing Agreement with Eurobio 204
Table 95: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 205
Table 96: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 206
Table 97: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 207
Table 98: I ncellDx Enters into Licensing Agreement with Claremont BioSolutions 208
Table 99: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 209
Table 100: AngioDynamics Enters into Licensing Agreement with EmboMedics 210
Table 101: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 211
Table 102: Biocartis Enters into Licensing and Development Agreement with Microbiome 212
Table 103: Esperite Enters into Agreement with Premaitha Health 213
Table 104: CBScientific Enters into Distribution Agreement with UTest 214
Table 105: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 215
Table 106: GeneThera Enters into Co-Development Agreement with Hudson Robotics 216
Table 107: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 217
Table 108: Ellen Enters into Distribution Agreement with Biosynex 218
Table 109: KromaTiD Enters into Distribution Agreement with Tebu-bio 219
Table 110: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 220
Table 111: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 222
Table 112: BioMerieux Enters into Licensing Agreement with Astute Medical 223
Table 113: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 224
Table 114: NoemaLife Enters into Distribution Agreement with Horiba Medical 225
Table 115: Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 226
Table 116: BioMerieux Enters into Co-Development Agreement with Illumina 227
Table 117: Enterome Enters into Co-Development Agreement with AbbVie 228
Table 118: Ingen Expands Distribution Agreement with One Lambda 229
Table 119: Integrated DNA Enters into Licensing Agreement with EliTech 230
Table 120: Clinical Genomics Enters into Licensing Agreement with CSIRO 231
Table 121: InnaVirVax Raises USD4 Million in Venture Financing 232
Table 122: Echosens Raises USD32.7 Million in Venture Financing 233
Table 123: HalioDx Raises USD8 Million in Series A Financing 234
Table 124: EyeBrain Raises USD1.5 Million in Venture Financing 236

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, France, Revenue ($m), USD Constant, 2007-2021 30
Figure 2: In Vitro Diagnostics Market, France, Revenue Mix ($m), 2014 32
Figure 3: In Vitro Diagnostics Market, France, Category Contribution (%), 2014 33
Figure 4: In Vitro Diagnostics Market, France, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Figure 5: In Vitro Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 6: In Vitro Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 7: In Vitro Diagnostics Market, France, Company Share (%) 2014 40
Figure 8: Clinical Chemistry Market, France, Revenue Mix ($m), 2014 42
Figure 9: Clinical Chemistry Market, France, Segment Contribution (%), 2014 43
Figure 10: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 11: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 12: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 13: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 14: Urine Analysis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 15: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 16: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 17: Urine Analysis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 18: Clinical Chemistry Market, France, Company Share (%) 2014 62
Figure 19: Genetic Testing Market, France, Revenue Mix ($m), 2014 64
Figure 20: Genetic Testing Market, France, Segment Contribution (%), 2014 65
Figure 21: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 66
Figure 22: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Figure 23: Genetic Testing Market, France, Company Share (%) 2014 71
Figure 24: Haematology Market, France, Revenue Mix ($m), 2014 73
Figure 25: Haematology Market, France, Segment Contribution (%), 2014 74
Figure 26: Haematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 75
Figure 27: Haematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 77
Figure 28: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 79
Figure 29: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 81
Figure 30: Haematology Reagents Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 83
Figure 31: Haemostasis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 32: Immunohaematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 87
Figure 33: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 89
Figure 34: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Figure 35: Haematology Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 36: Haemostasis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 37: Immunohaematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Figure 38: Haematology Market, France, Company Share (%) 2014 100
Figure 39: Histology And Cytology Market, France, Revenue Mix ($m), 2014 102
Figure 40: Histology And Cytology Market, France, Segment Contribution (%), 2014 103
Figure 41: Histology And Cytology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 104
Figure 42: Histology And Cytology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Figure 43: Histology And Cytology Market, France, Company Share (%) 2014 109
Figure 44: Immuno Chemistry Market, France, Revenue Mix ($m), 2014 111
Figure 45: Immuno Chemistry Market, France, Segment Contribution (%), 2014 112
Figure 46: Immuno Chemistry Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 114
Figure 47: Immuno Chemistry Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 116
Figure 48: Anemia Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 118
Figure 49: Disease Specific Immunochemistry Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 50: Endocrinology Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 122
Figure 51: IgE Allergy Blood Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 124
Figure 52: Immunochemistry Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 126
Figure 53: Immunochemistry Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 128
Figure 54: Vitamins Tests Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 130
Figure 55: Anemia Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Figure 56: Disease Specific Immunochemistry Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Figure 57: Endocrinology Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Figure 58: IgE Allergy Blood Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Figure 59: Immunochemistry Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Figure 60: Immunochemistry Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Figure 61: Vitamins Tests Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Figure 62: Immuno Chemistry Market, France, Company Share (%) 2014 147
Figure 63: Infectious Diagnostics Market, France, Revenue Mix ($m), 2014 149
Figure 64: Infectious Diagnostics Market, France, Segment Contribution (%), 2014 150
Figure 65: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 152
Figure 66: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 156
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Figure 69: Infectious Diagnostics Market, France, Company Share (%) 2014 161
Figure 70: Microbiology Culture Market, France, Revenue Mix ($m), 2014 163
Figure 71: Microbiology Culture Market, France, Segment Contribution (%), 2014 164
Figure 72: Microbiology Culture Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 165
Figure 73: Microbiology Culture Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 167
Figure 74: Microbiology Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 169
Figure 75: Microbiology Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Figure 76: Microbiology Culture Market, France, Company Share (%) 2014 174

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.